Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Gimsing

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Expert Opinion on Investigational Drugs|April 2, 2009
Belinostat: a new broad acting antineoplastic histone deacetylase inhibitorPeter Gimsing
European Journal of Haematology|April 17, 2013
Aberrant microRNA expression in multiple myelomaKonstantinos Dimopoulos, Peter Gimsing, Kirsten Grønbæk
Acta Haematologica|December 23, 2014
Characteristics and long-term outcome of patients with systemic immunoglobulin light-chain amyloidosisLærke Marie Nelson, Finn Gustafsson, Peter Gimsing
Clinical Chemistry|November 26, 2002
Simple method for quantification of Bence Jones proteinsMorten Salomo, Peter Gimsing, Lars B Nielsen
Journal of the Peripheral Nervous System : JPNS|December 28, 2020
Comparing neuropathy in multiple myeloma and AL amyloidosisMartin Ballegaard, Laerke Marie Nelson, Peter Gimsing
Scandinavian Journal of Gastroenterology|February 27, 2009
Primary (AL) amyloidosis with gastrointestinal involvementLone Galmstrup Madsen, Peter Gimsing, Frank V Schiødt
European Journal of Haematology|June 11, 2005
Autologous stem cell transplantation in multiple myeloma: outcome in patients with renal failureLene M Knudsen, Bendt Nielsen, Peter Gimsing, et al.
Danish Medical Journal|November 7, 2013
Primary localised cutaneous amyloidosis--a systematic reviewBritta Kaltoft, Grethe Schmidt, Anne Falensteen Lauritzen, et al.
British Journal of Haematology|July 9, 2003
How myeloma cells escape bisphosphonate-mediated killing: development of specific resistance with preserved sensitivity to conventional chemotherapeuticsMorten Salomo, Jesper Jurlander, Lars Bo Nielsen, et al.
European Journal of Haematology|March 24, 2018
Risk factors for blood stream infections in multiple myeloma: A population-based study of 1154 patients in DenmarkRasmus Sørrig, Tobias W Klausen, Morten Salomo, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Expert Opinion on Investigational Drugs|April 2, 2009
Belinostat: a new broad acting antineoplastic histone deacetylase inhibitorPeter Gimsing
European Journal of Haematology|April 17, 2013
Aberrant microRNA expression in multiple myelomaKonstantinos Dimopoulos, Peter Gimsing, Kirsten Grønbæk
Acta Haematologica|December 23, 2014
Characteristics and long-term outcome of patients with systemic immunoglobulin light-chain amyloidosisLærke Marie Nelson, Finn Gustafsson, Peter Gimsing
Clinical Chemistry|November 26, 2002
Simple method for quantification of Bence Jones proteinsMorten Salomo, Peter Gimsing, Lars B Nielsen
Journal of the Peripheral Nervous System : JPNS|December 28, 2020
Comparing neuropathy in multiple myeloma and AL amyloidosisMartin Ballegaard, Laerke Marie Nelson, Peter Gimsing
Scandinavian Journal of Gastroenterology|February 27, 2009
Primary (AL) amyloidosis with gastrointestinal involvementLone Galmstrup Madsen, Peter Gimsing, Frank V Schiødt
European Journal of Haematology|June 11, 2005
Autologous stem cell transplantation in multiple myeloma: outcome in patients with renal failureLene M Knudsen, Bendt Nielsen, Peter Gimsing, et al.
Danish Medical Journal|November 7, 2013
Primary localised cutaneous amyloidosis--a systematic reviewBritta Kaltoft, Grethe Schmidt, Anne Falensteen Lauritzen, et al.
British Journal of Haematology|July 9, 2003
How myeloma cells escape bisphosphonate-mediated killing: development of specific resistance with preserved sensitivity to conventional chemotherapeuticsMorten Salomo, Jesper Jurlander, Lars Bo Nielsen, et al.
European Journal of Haematology|March 24, 2018
Risk factors for blood stream infections in multiple myeloma: A population-based study of 1154 patients in DenmarkRasmus Sørrig, Tobias W Klausen, Morten Salomo, et al.
Pageof 6